Page 17 - Vaccine

India faces global challenges from position of strength, says RBI article

The article on 'State of the Economy', published in the April 2022 RBI Bulletin, said India enters Samvat 2079 having crested the third wave of the pandemic

Kejriwal govt should provide free booster dose: Delhi Congress president

He said that the lockdown and closure of schools will not be the solution to deal with the pandemic

Covid-19: Delhi govt says free precaution doses at its hospitals soon

The move comes as the national capital witnesses an uptick in coronavirus cases and a rise in positivity rate

SII, Bharat Biotech cut Covid vaccine prices for pvt hospitals to Rs 225

SII and Bharat Biotech have been major suppliers of Covid-19 vaccines to the government so far

Cadila Pharma launches world's first novel 3-dose vaccine against rabies

The three-dose vaccine, named as 'ThRabis', is a recombinant nano-particle based G protein vaccine which is prepared using Virus-like Particle technology

Govt okays booster Covid shot for all adults at private centres from Apr 10

Around 22.8 mn precaution or booster dose have been administered to healthcare and frontline workers along with senior citizens after the population segments opened up in the first week of January.

CoWIN now allows submitting request to rectify Covid vaccination date

The portal already has a feature that allows one to rectify inadvertent errors in name, year of birth and gender on vaccination certificates

Don't slack off

Vaccination programme cannot lose govt attention

SII, Bharat Biotech halt production of Covid vaccines as demand slips

High inventory, lack of fresh orders behind the decision; focus on non-Covid vax

US lawsuit may not impact India launch of Gennova's mRNA vaccine

The vaccine is now under review by the regulator, and if approved, it may be ready for launch in the Indian market and will be the first mRNA Covid vaccine to be available here.

Bharat Biotech slows down Covaxin production as it sees decrease in demand

'For the coming period, the company will focus on pending facility maintenance, process and facility optimization activities,' the Hyderabad-based company said

'India may come up with vaccine against tuberculosis by 2024'

Currently, the BCG vaccine is used among children at the time of birth

Finland recommends fourth Covid-19 vaccine dose to people above 80 years

Finland has recommended a fourth Covid-19 vaccine dose for people above 80 years and those living in care homes

Moderna says its low-dose Covid vaccine shots work for kids under 6

The younger the child, the smaller the dose being tested. Moderna said a quarter of the dose it uses for adults worked well for youngsters under age 6

DCGI gives nod to phase-3 clinical trial of Covid vaccine Covovax

The vaccine has not been included in the country's inoculation programme against Covid-19

Four vaccines approved for those below 18 years, govt tells Rajya Sabha

The Central Drugs Standard Control Organization in consultation with Subject Expert Committee has approved four COVID-19 vaccines for restricted use in emergency situation for those aged below 18 years, the Rajya Sabha was informed on Tuesday. The four vaccines which have been approved are Zydus Cadila's ZyCovD (in the age group of 12 years and older), Bharat Biotech's Covaxin (for >2 to <18 years age group), Biological E's Corbevax (for =5 to <18 years age group) and Serum Institute of India's Covovax (for >12 to <18 years age group), Minister of State for Health Bharati Pravin Pawar said in a written reply. The National COVID-19 vaccination programme was expanded to include adolescents aged 15 to 18 years from January 3, 2022. It was further expanded to children of age group 12 -14 years from March 16. The National Covid vaccination programme is guided by National Technical Advisory Group on Immunization (NTAGI) and the National Expert Group on Vaccine ...

Poultry vaccine maker Hester Bio enters pet care, no fresh investment seen

Is now looking to add dermatology, nutrition, grooming, anti-infective and specialty products in this segment

India's Covid vaccination drive epitome of power of Sabka Prayas: Mandaviya

India crossed 750 mn vaccinations milestone on September 7, 2021, and achieved a milestone of 1 bn vaccinations on October 21, 2021

Wockhardt, Serum Institute of India tie up to make vaccines in UK

SII has supplied the AstraZeneca-Oxford vaccine to the UK already, and having a fill-and-finish facility in the UK would help the firm to have closer access to the UK and EU markets.

Two primary doses followed by booster crucial for all: Top virologist

'Immunisation schedule must be completed by all individuals if we have to win this war against Covid,' he said